Marta Trapero‐Bertran
Biographic Data
| ID | 7759713 |
|---|---|
| NAME | Marta Trapero‐Bertran |
| GIVEN NAMES | Marta |
| FAMILY NAME | Trapero‐Bertran |
| SIGNATURE | BERTRAN M T |
| AFFILIATIONS | Universitat Internacional de Catalunya |
| ORCID | 0000-0002-9233-1776 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Reform of economic evaluation of medicines in Spain: Proposals from the Advisory Committee for Pharmaceutical Financing
This paper describes the reforms recommended by the Advisory Committee on the Financing of Pharmaceuticals (CAPF) for the National Health System (NHS) of Spain from 2019 to 2024 for the drug pricing and reimbursement process, to integrate economic evaluations and improve efficiency and sustainability. The CAPF has proposed a three-phase reform of the economic evaluation (EE) and budget impact analysis (BIA) processes. The first phase involves the…
Guideline for the economic evaluation of medicines: A proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing
In 2023, the General Directorate of Pharmacy of the Ministry of Health commissioned the Advisory Committee on the Financing of Pharmaceuticals for the National Health System (CAPF, Comité Asesor para la Financiación de la Prestación Farmacéutica del Sistema Nacional de Salud ) to produce a guideline for the evaluation of the efficiency of medicines. The aim of this methodological note is to present their main points. The guideline includes 17 dim…
Análisis de la evolución en el acceso a los medicamentos huérfanos en España
Evaluar el acceso al mercado de los medicamentos huérfanos en España que a fecha de 31 de diciembre de 2017 tuvieran vigente su designación, y para aquellos comercializados en España estimar los tiempos entre la asignación de código nacional (CN) por parte de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) y la fecha de comercialización efectiva. La base de datos para identificar los medicamentos huérfanos autorizados por la Ag…
Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: The TackSHS project protocol
The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants. The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countri…
Social, economic and family factors associated with binge drinking in Spanish adolescents
(ClinicalTrials.gov): NCT03288896. Registration date: September 20, 2017. "Retrospectively registered
Gender Differences in Labour Losses Associated with Smoking-Related Mortality
The aim of this paper was to estimate the number of premature deaths, years of potential productive life lost (YPPLL) and labour losses attributable to tobacco smoking due to premature death by gender for the Spanish population. The human capital approach was applied. Employment, gross wage and death data were obtained from the Spanish National Institute of Statistics. Relative risks of death due to cigarette smoking and former smoking were appli…
The influence of education on the access to childhood immunization: The case of Spain
This paper evidenced the presence of an education gradient for specific preventive care through the public health system and visits to the GP without any particular disease or advice for specific vaccinations
Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: The CRIVERVA study
ClinicalTrials.gov Identifier: NCT01373723
No prominent works on this page.
Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: The CRIVERVA study
ClinicalTrials.gov Identifier: NCT01373723
The influence of education on the access to childhood immunization: The case of Spain
This paper evidenced the presence of an education gradient for specific preventive care through the public health system and visits to the GP without any particular disease or advice for specific vaccinations
Gender Differences in Labour Losses Associated with Smoking-Related Mortality
The aim of this paper was to estimate the number of premature deaths, years of potential productive life lost (YPPLL) and labour losses attributable to tobacco smoking due to premature death by gender for the Spanish population. The human capital approach was applied. Employment, gross wage and death data were obtained from the Spanish National Institute of Statistics. Relative risks of death due to cigarette smoking and former smoking were appli…
Análisis de la evolución en el acceso a los medicamentos huérfanos en España
Evaluar el acceso al mercado de los medicamentos huérfanos en España que a fecha de 31 de diciembre de 2017 tuvieran vigente su designación, y para aquellos comercializados en España estimar los tiempos entre la asignación de código nacional (CN) por parte de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) y la fecha de comercialización efectiva. La base de datos para identificar los medicamentos huérfanos autorizados por la Ag…
Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: The TackSHS project protocol
The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants. The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countri…
Social, economic and family factors associated with binge drinking in Spanish adolescents
(ClinicalTrials.gov): NCT03288896. Registration date: September 20, 2017. "Retrospectively registered
Reform of economic evaluation of medicines in Spain: Proposals from the Advisory Committee for Pharmaceutical Financing
This paper describes the reforms recommended by the Advisory Committee on the Financing of Pharmaceuticals (CAPF) for the National Health System (NHS) of Spain from 2019 to 2024 for the drug pricing and reimbursement process, to integrate economic evaluations and improve efficiency and sustainability. The CAPF has proposed a three-phase reform of the economic evaluation (EE) and budget impact analysis (BIA) processes. The first phase involves the…
Guideline for the economic evaluation of medicines: A proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing
In 2023, the General Directorate of Pharmacy of the Ministry of Health commissioned the Advisory Committee on the Financing of Pharmaceuticals for the National Health System (CAPF, Comité Asesor para la Financiación de la Prestación Farmacéutica del Sistema Nacional de Salud ) to produce a guideline for the evaluation of the efficiency of medicines. The aim of this methodological note is to present their main points. The guideline includes 17 dim…
Medicine (6 works) · Demography (4 works) · Demography (4 works) · Environmental health (4 works) · Population (4 works) · Public health (4 works) · Biostatistics (3 works) · Business (3 works) · Family medicine (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works)